Lentinan vs Thymosin Alpha-1 — Peptide Comparison

Lentinan vs Thymosin Alpha-1 — Peptide Comparison Lentinan vs Thymosin Alpha-1 — compare dosing, benefits, safety profiles, side effects, and how they stack. See which peptide is right for you. At a Glance Dose Range Lentinan 2–10 mg Thymosin Alpha-1 1.6–3.2 mg Frequency Once weekly Twice weekly Administration Intravenous infusion Subcutaneous injection Cycle Length 8-12 weeks Onset Speed Moderate (1-2 weeks) Evidence Level Moderate human trials (Phase 1-2) Efficacy Immune Healing & Recovery Anti-Aging Immune Activation Infection Fighting Immune Balance Technical Data Molecular Formula (C6H10O5)n (repeating glucose units) Molecular Weight ~500,000 g/mol (varies by preparation) Half-Life Approximately 15-30 minutes (IV administration) Bioavailability 100% (intravenous administration) CAS Number 37339-90-5 C129H215N33O55 3108.32 g/mol Approximately 2 hours High when injected subcutaneously (rapid absorption, peak at ~2 hours) 62304-98-7 Protocols starting 1 mg per dose Continued alongside chemotherapy cycles Established clinical regimen in Japan (approved 1985 as a biological response modifier for gastric cancer): 1 mg IV twice weekly combined with chemotherapy such as tegafur or 5-FU [1][6]. standard 2 mg per dose Once weekly (some protocols every 2-3 weeks) Alternative approved IV schedule: 2 mg once weekly; more recent protocols give 2 mg every 2-3 weeks. Used as an immunomodulatory adjunct to S-1/tegafur-based chemotherapy in advanced/recurrent gastric cancer [1][6]. 1.6 mg Twice weekly (3-4 days apart) 6-12 months Established clinical dose for thymalfasin (Zadaxin); body-surface-scaled as 900 mcg/m2 [4][6]. Phase III chronic hepatitis B trials used 1.6 mg SC twice weekly for 6-12 months [4]. advanced 1.6 mg daily, then 1.6 mg twice weekly Daily for an initial loading period, then twice weekly 12+ weeks Some immune-adjuvant and acute protocols front-load with daily dosing before settling to the standard twice-weekly schedule [4][6]. Applications Advanced Gastric Cancer Lentinan's primary and best-studied indication is as an adjuvant to chemotherapy for unresectable and recurrent gastric cancer. A multi-institutional randomized trial demonstrated significantly extended survival (297 vs 199 days median) and dramatically improved one-year survival rates (49.1% vs 0%). Lung Cancer Adjuvant Therapy A 12-year review of clinical studies in China demonstrated that lentinan combined with chemotherapy improves outcomes in lung cancer patients, with a meta-analysis confirming increased chemotherapy efficacy and improved quality of life. Cancer Patients Needing Quality of Life Support Clinical trials consistently show lentinan improves patient quality of life during cancer treatment, particularly appetite and sleep quality, while reducing the toxic side effects of chemotherapy and enabling treatment continuity. Immunocompromised Patients Phase 1/2 clinical trials in HIV-positive patients have explored lentinan's ability to enhance immune function when combined with antiretroviral therapy, though this application remains investigational. Chronic Hepatitis B or C Support Thymosin Alpha-1 has its strongest clinical evidence here. Multiple trials show it helps clear viral loads and normalize liver enzymes, especially when combined with antiviral medications. It's approved in over 30 countries specifically for hepatitis treatment. Cancer Treatment Support When used alongside chemotherapy, Thymosin Alpha-1 may help maintain immune function that chemo tends to suppress. Research in lung cancer, melanoma, and liver cancer shows improved outcomes when added to standard treatments. It helps your immune system keep fighting even during tough treatments. Age-Related Immune Decline As you age, your thymus shrinks and produces less thymosin naturally—a process called immunosenescence. Supplementing with Thymosin Alpha-1 may help compensate, keeping your immune defenses more youthful and responsive. Think of it as replacing what your body makes less of over time. Severe Infection Recovery In sepsis and critical infections, Thymosin Alpha-1 has shown promise for reducing mortality by helping restore immune balance. It's particularly interesting because it modulates immunity rather than just boosting it—calming overreaction while enhancing pathogen-fighting ability. Safety Profile Common Fever and chills Infusion site discomfort Transient fatigue Nausea Uncommon Chest tightness or back pain Granulocytopenia Serious Anaphylaxis Severe allergic reaction / Anaphylaxis Injection site reactions Mild fatigue Flu-like symptoms Mild fever Lymph node awareness Allergic reaction Research Status FDA Status Research compound Safety Overview Lentinan is a beta-1,3-glucan polysaccharide (not a true peptide) extracted from shiitake mushroom with a 40-year safety record in Japanese and Asian oncology practice. Parenteral lentinan shows excellent tolerability as an immune adjuvant with minimal systemic toxicity—hepatotoxicity and nephrotoxicity are essentially absent in clinical use. Fever and localized reactions at injection sites (5-15% of patients) are the documented side effects. The compound works through pattern recognition receptors (Dectin-1, TLR-2) to enhance NK cell and macrophage function without inducing autoimmunity. Contraindications xKnown hypersensitivity to lentinan or shiitake mushroom components xHistory of anaphylactic reactions to β-glucan polysaccharides xSevere immunosuppression where immune activation is contraindicated xActive autoimmune disease in flare (immune stimulation could worsen) FDA approved for other use Thymosin Alpha-1 has one of the most extensive safety records of any peptide, with decades of clinical use across multiple countries. Studies consistently report minimal side effects—mostly limited to mild injection site reactions. The 2-hour half-life means it doesn't accumulate in your system. It's been used safely in thousands of patients with hepatitis, cancer, and other serious conditions. xOrgan transplant recipients on immunosuppressants xActive autoimmune disease flares xKnown allergy to thymosin peptides xPregnancy or breastfeeding xChildren under 18 without medical supervision Decision Guide Choose Lentinan if... Adjunctive cancer therapy (especially gastric cancer) Immune system enhancement during chemotherapy Improving quality of life for cancer patients Supporting immune function in immunocompromised individuals Choose Thymosin Alpha-1 if... Immune system strengthening Chronic infection support Cancer adjunct therapy Healthy aging immune support